Clinical outcomes of patients with chemo-refractory pancreatic adenocarcinoma participating in phase I clinical trials

被引：0
|
作者：
Sasaki, M. [1 ]
Satake, T. [1 ]
Watanabe, K. [1 ]
Imaoka, H. [1 ]
Shibuki, T. [1 ]
Inoue, K. [1 ]
Taira, T. [1 ]
Igarashi, G. [1 ]
Yamaguchi, S. [1 ]
Mitsunaga, S. [1 ]
Ikeda, M. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
358P
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [1] Clinical outcomes of patients with gastrointestinal malignancies participating in phase I clinical trials
    Mahipal, Amit
    Burke, Nancy
    Wapinsky, Georgine
    Bertels, Barbara
    Juan, TzuHua
    Lee, Jae K.
    Lush, Richard
    Sullivan, Daniel
    Denson, Aaron
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [2] Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials
    Denson, Aaron
    Burke, Nancy
    Wapinsky, Georgine
    Bertels, Barbara
    Juan, Tzu-Hua
    Lee, Jae
    Springett, Gregory M.
    Strosberg, Jonathan R.
    Kim, Richard D.
    Sullivan, Dan M.
    Mahipal, Amit
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (02): : 133 - 139
  • [3] Phase I clinical trial of XK469 in patients with chemo-refractory solid tumors.
    Alousi, AM
    Parchment, R
    Boinpally, R
    Gadgeel, S
    Weigand, R
    McCormick, J
    Lorusso, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 132S - 132S
  • [4] A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
    A T Brunetto
    D Sarker
    D Papadatos-Pastos
    R Fehrmann
    S B Kaye
    S Johnston
    M Allen
    J S De Bono
    C Swanton
    British Journal of Cancer, 2010, 103 : 607 - 612
  • [5] A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit
    Brunetto, A. T.
    Sarker, D.
    Papadatos-Pastos, D.
    Fehrmann, R.
    Kaye, S. B.
    Johnston, S.
    Allen, M.
    De Bono, J. S.
    Swanton, C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (05) : 607 - 612
  • [6] Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
    Jean-Marie Michot
    Lina Benajiba
    Laura Faivre
    Capucine Baldini
    Lelia Haddag
    Clement Bonnet
    Christophe Massard
    Frederic Bigot
    Camille Bigenwald
    Benjamin Verret
    Zoé A. P. Thomas
    Andrea Varga
    Anas Gazzah
    Antoine Hollebecque
    David Ghez
    Julien Lazarovici
    Rastilav Balheda
    Aurore Jeanson
    Sophie Postel-Vinay
    Alina Danu
    Jean-Charles Soria
    Xavier Paoletti
    Vincent Ribrag
    Investigational New Drugs, 2018, 36 : 62 - 74
  • [7] Outcomes and prognostic factors for relapsed or refractory lymphoma patients in phase I clinical trials
    Michot, Jean-Marie
    Benajiba, Lina
    Faivre, Laura
    Baldini, Capucine
    Haddag, Lelia
    Bonnet, Clement
    Massard, Christophe
    Bigot, Frederic
    Bigenwald, Camille
    Verret, Benjamin
    Thomas, Zoe A. P.
    Varga, Andrea
    Gazzah, Anas
    Hollebecque, Antoine
    Ghez, David
    Lazarovici, Julien
    Balheda, Rastilav
    Jeanson, Aurore
    Postel-Vinay, Sophie
    Danu, Alina
    Soria, Jean-Charles
    Paoletti, Xavier
    Ribrag, Vincent
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) : 62 - 74
  • [8] Clinical outcome and survival of patients participating in oncology phase I trials
    Florescu, A.
    Chau, N. G.
    Chan, K. K.
    Wang, L.
    Chen, E. X.
    Oza, A. M.
    Siu, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Biomarker selection for patients participating in phase I clinical trials.
    Eberst, Lauriane
    Basse, Clemence
    Morelle, Magali
    Simmet, Victor
    Terret, Catherine
    Pissaloux, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
    Douma, Joeri A. J.
    Buffart, Laurien M.
    Sedhom, Ramy
    Labots, Mariette
    van der Houven van Oordt, Willemien C.
    Skardhamar, Mikkjal
    De Felice, Anthony
    Lee, Esther
    Dharmaraj, Divya
    Azad, Nilofer S.
    Carducci, Michael A.
    Verheul, Henk M. W.
    CANCERS, 2021, 13 (10)
12345